BioStem Technologies, Inc. (OTCMKTS:BSEM – Get Free Report)’s stock price was up 0.6% during mid-day trading on Thursday . The stock traded as high as $13.50 and last traded at $13.27. Approximately 40,150 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 68,449 shares. The stock had previously closed at $13.19.
BioStem Technologies Price Performance
The business’s 50 day simple moving average is $14.82 and its 200 day simple moving average is $13.85. The stock has a market cap of $220.92 million, a P/E ratio of 19.51 and a beta of -0.53.
About BioStem Technologies
BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.
Featured Articles
- Five stocks we like better than BioStem Technologies
- 3 REITs to Buy and Hold for the Long Term
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- Want to Profit on the Downtrend? Downtrends, Explained.
- 5 Best Gold ETFs for March to Curb Recession Fears
- Why Invest in High-Yield Dividend Stocks?
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
